The price of Xofluza 40mg can vary based on several factors, including insurance coverage, pharmacy, and location. While a specific price for the 40mg tablet is not universally published, the typical out-of-pocket cost for a single 40mg tablet of Xofluza (baloxavir marboxil) can range from approximately $170 to over $300 without insurance [1].
What influences Xofluza's price?
The retail price of Xofluza is influenced by factors such as the drug manufacturer's pricing strategies, the wholesale acquisition cost, and the markups applied by pharmacies [1]. Insurance plans play a significant role, with copayments or coinsurance amounts differing widely depending on the specific policy. Manufacturer coupons or patient assistance programs may also be available to reduce out-of-pocket expenses for eligible individuals [1].
How does Xofluza dosing affect cost?
Xofluza is available in different dosage strengths, including 40mg and 80mg tablets, as well as a 10mg dispersible tablet. The 40mg dosage is typically prescribed for children aged 12 and older, and for adults under 176 pounds (80 kg). The total cost for a course of treatment would depend on the number of tablets required for the prescribed dosage regimen [2]. For example, an adult weighing over 176 pounds would typically receive an 80mg dose, which might involve one 80mg tablet or two 40mg tablets, impacting the overall cost [2].
Are there ways to get Xofluza at a lower cost?
Patients may be able to reduce their Xofluza costs through prescription discount programs or by checking prices at different pharmacies. Inquire with your insurance provider about formulary coverage and potential copay assistance. The manufacturer of Xofluza, Roche, may offer savings programs for eligible patients [1].
When does Xofluza's patent expire?
Information regarding the specific patent expiry dates for Xofluza (baloxavir marboxil) can be found through specialized patent databases. DrugPatentWatch.com tracks patent information for pharmaceutical products [3]. Understanding patent expiries is crucial for anticipating the potential introduction of generic alternatives, which typically leads to lower drug prices.
Who manufactures Xofluza?
Xofluza is manufactured by Roche, a global pharmaceutical company [2].
What is Xofluza used for?
Xofluza is an antiviral medication used for the treatment of influenza (flu) in adults and children 12 years of age and older. It is also approved for the prevention of influenza after close contact with an infected person [2]. It works by inhibiting the cap-dependent endonuclease activity of the influenza virus polymerase basic protein 2 (PB2), which is essential for viral replication [2].
---
Sources:
[1] DrugPatentWatch.com (Various data related to drug pricing and manufacturer information)
[2] Roche (Manufacturer information on Xofluza)
[3] DrugPatentWatch.com (Patent information for baloxavir marboxil)